Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

Dentin Hypersensitivity Reduction Efficacy Clinical

← catalyst calendar

NCT07738198

Sponsored by Colgate Palmolive (industry) · CL — their whole pipeline →.

Phase
Phase 3
Status
Completed
Study type
Interventional
Design
Randomized · Quadruple · Treatment
Enrollment
116actual
Sites
1
Country
United States

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-09-03

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2018-11-26actualWhen the study began enrolling
Primary completion2018-12-08actualThe date the last participant is measured for the primary outcome — the readout window
Study completion2018-12-08actualThe whole study's end, after follow-up
First posted2026-07-31actualWhen this record first appeared on the registry
Results postedWhen the sponsor posted results to the registry
Record updated2026-07-31actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Condition

  • Dental Hypersensitivity

Interventions

  • Drug: 0.454% stannous fluoride toothpaste
  • Drug: 5% potassium nitrate
  • Drug: 0.76% sodium monofluorophosphate

Primary outcomes

what the primary-completion date above is the date OF
Tactile Sensitivity using the Yeaple Electronic Force Sensing Probe
measured baseline, 1 day, 3 day, 7 day
Air Sensitivity using the Schiff Cold Air Sensitivity Scale
measured baseline, 1 day, 3 day, 7 day

Permalink · CL's whole pipeline · Catalyst calendar · Every registered study · What changed